Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by FibroBiologics, Inc.

< Previous 1 2 3 Next >
News headline image
FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics CEO Issues Letter to Shareholders
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Compliant with All Nasdaq Listing Requirements
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Closing of $3 Million Public Offering
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Pricing of $3 Million Public Offering
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at the BIO Investment & Growth Summit
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Granted Extension by Nasdaq to Regain Compliance
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at the DealFlow Discovery Conference
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics CEO Issues Letter to Shareholders
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From FibroBiologics, Inc.
Via GlobeNewswire
Tickers FBLG
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.